MktsMarkets

Medpace Holdings, Inc.
NASDAQ: MEDPKey statistics
MEDP News
Stories mentioning MEDP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 706,604 | 708,450 | 659,903 | 603,311 | 558,570 | 536,589 | 533,317 | 528,104 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 47,917 | 44,916 | 48,082 | 46,664 | 57,897 | 45,433 | 49,217 | 41,453 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 141,503 | 153,269 | 141,808 | 126,335 | 113,523 | 125,378 | 112,273 | 105,150 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 971.00 | (158.00) | (489.00) | (2,875) | (1,816) | 621.00 | (1,025) | (133.00) |
| Pretax Income | 147,591 | 156,833 | 142,836 | 124,538 | 118,170 | 133,882 | 118,776 | 110,482 |
| Tax Provision | 23,721 | 21,700 | 31,701 | 34,278 | 3,575 | 16,864 | 22,350 | 22,131 |
| Net Income (Loss) | 123,870 | 135,133 | 111,135 | 90,260 | 114,595 | 117,018 | 96,426 | 88,351 |
| Earnings Per Share (Basic) | 4.35 | 4.68 | 3.95 | 3.16 | 3.77 | 3.78 | 3.11 | 2.85 |
| Earnings Per Share (Diluted) | 4.28 | 4.58 | 3.86 | 3.10 | 3.67 | 3.66 | 3.01 | 2.75 |
| Weighted Average Shares Outstanding (Basic) | 28,445 | 28,846 | 28,136 | 28,601 | 30,387 | 30,957 | 31,047 | 30,990 |
| Weighted Average Shares Outstanding (Diluted) | 28,962 | 29,527 | 28,817 | 29,143 | 31,196 | 32,014 | 32,088 | 32,086 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MEDP
Medpace Holdings, Inc. (NASDAQ: MEDP) is a stock listed on the Nasdaq Stock Market under the ticker symbol MEDP. It last traded at $669.20 (Oct 23, 2026, 4:00 PM ET), up 2.3% on the day. That gives Medpace a market capitalisation of $18.7B and a price-to-earnings ratio of 38.0.
Over the past 52 weeks MEDP has traded between $373.00 and $684.52.
Revenue for the quarter ended Mar 31, 2026 was $706.6M; net income $123.9M. Revenue was up 26.5% from $558.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $706.6M | $123.9M | 17.5% |
| Dec 31, 2025 | $708.5M | $135.1M | 19.1% |
| Sep 30, 2025 | $659.9M | $111.1M | 16.8% |
| Jun 30, 2025 | $603.3M | $90.3M | 15.0% |
From Medpace’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…